IP Verse

High Througput Methods For Characterization Of Antibodies - EP2076769

The patent EP2076769 was granted to Genmab on Apr 25, 2018. The application was originally filed on Oct 2, 2007 under application number EP07817819A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2076769

GENMAB
Application Number
EP07817819A
Filing Date
Oct 2, 2007
Status
Granted And Under Opposition
Mar 23, 2018
Grant Date
Apr 25, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MORPHOSYSJan 25, 2019SPILLERWITHDRAWN

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTUS2002182643
INTERNATIONAL-SEARCH-REPORTUS2004018198
INTERNATIONAL-SEARCH-REPORTWO2006055371
INTERNATIONAL-SEARCH-REPORTWO2006099875
OPPOSITIONUS2002182643
OPPOSITIONUS2004018198
OPPOSITIONUS4689311
OPPOSITIONUS5045451
OPPOSITIONWO2006055371
OPPOSITIONWO2006099875

Non-Patent Literature (NPL) Citations (11) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
INTERNATIONAL-SEARCH-REPORT- DIAZ TOMAS M ET AL, "FDA/PI flow cytometry assay of complement-mediated cytotoxicity of antibodies generated during xenotransplantation", CYTOMETRY, (200411), vol. 62A, no. 1, ISSN 0196-4763, pages 54 - 60, XP002479006 [X] 30,31 * abstract, p. 55, col. 1, paragraph 3, col. 2, paragraph 3, Discussion * [A] 17-29,32
INTERNATIONAL-SEARCH-REPORT- MARTIN ROBERT M ET AL, "DNA labeling in living cells", CYTOMETRY. PART A, JOHN WILEY, HOBOKEN, NJ, US, (20050901), vol. 67, no. 1, ISSN 1552-4922, pages 45 - 52, XP009092963 [Y] 17-29,32 * abstract, discussion *
INTERNATIONAL-SEARCH-REPORT- LEE-MACARY ALICE E ET AL, "Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide", JOURNAL OF IMMUNOLOGICAL METHODS, (20010601), vol. 252, no. 1-2, ISSN 0022-1759, pages 83 - 92, XP002479005 [X] 30,31 * the whole document * [Y] 17-29,32
INTERNATIONAL-SEARCH-REPORT- WILKINSON R W ET AL, "Antibody-dependent cell-mediated cytotoxicity: a flow cytometry-based assay using fluorophores", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, (20011201), vol. 258, no. 1-2, ISSN 0022-1759, pages 183 - 191, XP004311928 [X] 30,31 * the whole document * [Y] 17-29,32
OPPOSITION- TILL MARC et al., "An Assay That Predicts the Ability of Monoclonal Antibodies to FormPotent Ricin A Chain-containing Immunotoxins", CANCER RESEARCH, (19880301), vol. 48, no. 5, pages 1119 - 1123, XP055560527-
OPPOSITION- WELTMAN J. K. et al., "Rapid Screening with Indirect Immunotoxin for Monoclonal Antibodies against Human Small Cell Lung Cancer", CANCER RESEARCH, (19871101), vol. 47, no. 21, pages 5552 - 5556, XP055560533-
OPPOSITION- DIAZ TOMAS M et al., "FDA/PI flow cytometry assay of complement-mediated cytotoxicity of antibodies generated during xenotransplantation : Complement Cytotoxicity by Flow Cytometry", CYTOMETRY PART A, (20041101), vol. 62A, no. 1, pages 54 - 60, XP055560299
OPPOSITION- MARTIN ROBERT M et al., "DNA Labeling in Living Cells", CYTOMETRY. PART A, (20050901), vol. 67A, pages 45 - 52, XP055560293
OPPOSITION- CASALINI P. et al., "A critical comparison of three internalization assays applied to the evaluation of a given mAb as a toxin-carrier candidate.", CANCER - IMMUNOLOGY IMMUNOTHERAPY, (19930000), vol. 37, pages 54 - 60, XP055560318
OPPOSITION- LEE-MACARY ALICE E et al., "Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide", J. IMMUNOL. METH., (20010601), vol. 252, no. 1-2, pages 83 - 92, XP055560288
OPPOSITION- WILKINSON R W et al., "Antibody-dependent cell-mediated cytotoxicity: a flow cytometry-based assay using fluorophores", J. IMMUNOL. METH., (20011201), vol. 258, no. 1-2, pages 183 - 191, XP055560272

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents